Literature DB >> 9619107

Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.

V Butterweck1, F Petereit, H Winterhoff, A Nahrstedt.   

Abstract

It has been shown recently that the fraction IIIc of a crude extract of Hypericum perforatum, (St. John's wort) that contained both hypericin (1) and pseudohypericin (2), was remarkably active in the rats forced swimming test (FST) after Porsolt. However, neither of the naphthodianthrones isolated from this fraction were sufficiently effective when administered suspended in water. The solubility of 1 and 2 is remarkably increased in the presence of a fraction containing procyanidins, especially procyanidin B2, which is present also in the active Hypericum fraction IIIc. The cooperative effect of procyanidins significantly increased the in vivo effects of 1 and 2, which exhibited inverted U-shaped dose response curves, in the FST. The anti-immobility effect of solubilized 1 and 2 was antagonized by the dopamine antagonist sulpiride. These data indicate that naphthodianthrones are antidepressant constituents of H. perforatum and suggest that the dopaminergic system is involved in their action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619107     DOI: 10.1055/s-2006-957437

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  18 in total

1.  Use of hypericum as antidepressant. Valid measure of antidepressant efficacy in primary care is needed.

Authors:  A Thornett
Journal:  BMJ       Date:  2000-04-22

2.  Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.

Authors:  Steffen Bauer; Elke Störmer; Andreas Johne; Hagen Krüger; Klemens Budde; Hans-Hellmut Neumayer; Ivar Roots; Ingrid Mai
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

Review 3.  Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.

Authors:  Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.

Authors:  Birgit Kraus; Horst Wolff; Erich F Elstner; Jörg Heilmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

5.  Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels.

Authors:  Y Wang; X Shi; Z Qi
Journal:  Br J Pharmacol       Date:  2010-03-02       Impact factor: 8.739

6.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

Review 7.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

Review 8.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction.

Authors:  Kimberly D P Hammer; Matthew L Hillwig; Jeffrey D Neighbors; Young-Je Sim; Marian L Kohut; David F Wiemer; Eve S Wurtele; Diane F Birt
Journal:  Phytochemistry       Date:  2008-08-15       Impact factor: 4.072

10.  A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease.

Authors:  Xia Wang; Xue Xu; Weiyang Tao; Yan Li; Yonghua Wang; Ling Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.